FMP
ANI Pharmaceuticals, Inc.
ANIP
NASDAQ
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
53.35 USD
-0.91 (-1.71%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Nikhil Lalwani
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
exchange
NASDAQ
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and...
CIK
0001023024
ISIN
US00182C1036
CUSIP
00182C103
Address
210 Main Street West
Phone
218 634 3500
Country
US
Employee
642
IPO Date
May 5, 2000
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
ANIP Financial Summary
CIK
0001023024
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
00182C103
ISIN
US00182C1036
Country
US
Price
53.35
Beta
0.71
Volume Avg.
248.69k
Market Cap
1.12B
Shares
-
52-Week
52.0-70.81
DCF
-55.7
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-113.51
P/B
-
Website
https://www.anipharmaceuticals.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ANIP News
It looks like there's no news available.
